Rapport Therapeutics, Inc. (RAPP)
(Delayed Data from NSDQ)
$14.43 USD
+0.39 (2.78%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $14.38 -0.05 (-0.35%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Rapport Therapeutics, Inc. has a market cap of $512.43M, which represents its share price of $14.04 multiplied by its outstanding shares number of 36.50M. As a small-cap company, RAPP's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
RAPP 14.43 +0.39(2.78%)
Will RAPP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RAPP based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for RAPP
ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Rapport Therapeutics, Inc. (RAPP) Receives a Buy from Citizens JMP
Citizens JMP pharmaceuticals analysts hold analyst/industry conference call
RAPP: JMP Securities Reiterates Market Outperform Rating with $28 Target | RAPP Stock News
Citizens JMP pharmaceuticals analysts hold analyst/industry conference call